Fig. 3From: Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancerForest plot of IRX-2 immunotherapy effects on lymphocyte subsets. PD-L1: programmed death ligand 1; CI: confidence intervalBack to article page